Industry News
Sigma-Aldrich signs exclusive distribution agreement with Roche
Following an exclusive distribution agreement signed last week, life science company Sigma-Aldrich will employ its sales, marketing and e-commerce expertise for the exclusive worldwide distribution of the Biochemical Reagents product portfolio from Roche. [ + ]
GATC Biotech offers full access to QIAGEN's Ingenuity Variant Analysis
GATC Biotech clients will be provided with full access to QIAGEN's Ingenuity Variant Analysis solution for analysis and interpretation of genetic data, complementing GATC's InView Human Exome and providing customers with an integrated solution to identify causal variants in their exome sequencing data. [ + ]
Final Growth Centre chairs announced
The Australian Government has announced the chairs of its Medical Technologies and Pharmaceuticals Growth Centre and Oil, Gas and Energy Resources Growth Centre.
[ + ]Why is there no generic insulin?
Researchers from Johns Hopkins University have delved into the history of the diabetes drug insulin in the hope of understanding why a generic version has never been made available in the US. [ + ]
Scientists to converge on Sydney for annual ARCS congress
The 2015 ARCS Sydney Scientific Congress will once again offer one of the premier events of the year for professionals in the development and commercialisation of therapeutics. [ + ]
Why is there no generic insulin?
Researchers from Johns Hopkins University have delved into the history of the diabetes drug insulin in the hope of understanding why a generic version has never been made available in the US. [ + ]
Plant science competition for Australian school students
The Queensland Department of Agriculture and Fisheries (DAF) has officially opened the 2015 Hermitage Research Facility Schools Plant Science Competition - an annual event that aims to stimulate an interest in agriculture and science in young Australians. [ + ]
RV Investigator to undertake maiden voyage
The Australian scientific research vessel Investigator, which was commissioned into service in December 2014, will this week embark on its maiden research voyage. [ + ]
Alzheimer's treatment with ultrasound technology
University of Queensland researchers have discovered that non-invasive ultrasound technology can be used to treat Alzheimer's disease and restore memory in mice, breaking apart the neurotoxic amyloid-β (Aβ) plaques that result in cognitive decline.
[ + ]Mitochondria can move into cancer cells
A research collaboration between Griffith University and New Zealand's Malaghan Institute has discovered that mitochondria are capable of passing through the healthy membrane of a host cell into defective tumour cells.
[ + ]Explaining malaria protection in blood type O
Scientists from Sweden's Karolinska Institutet have explained the mysterious mechanism which protects people with blood type O from dying of severe malaria. [ + ]
Explaining malaria protection in blood type O
Scientists from Sweden's Karolinska Institutet have explained the mysterious mechanism which protects people with blood type O from dying of severe malaria. [ + ]
QIAGEN acquires circulating tumour cell technology
QIAGEN has expanded its portfolio of liquid biopsies through the acquisition of an innovative technology that enables enrichment and molecular analysis of circulating tumour cells (CTCs) from blood samples. [ + ]
ToolGen licenses CRISPR/Cas9 technology to Thermo Fisher Scientific
Korean biotechnology company ToolGen will license its CRISPR/Cas9 intellectual property portfolio to Thermo Fisher Scientific. Thermo Fisher will utilise the technology to develop and market CRISPR reagent kits. [ + ]
Bacteria-resistant catheters to reduce infection
Flinders University researchers are undertaking a project to reduce urinary tract infections associated with the use of catheters during hospital stays. [ + ]
